Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention of postoperative delirium in elderly patients under general anesthesia
ChiCTR-IPR-17011984Phase 4Not yet recruiting
- Sponsor
- 904th Hospital of the Joint Logistic Support Force
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin in postoperative delirium (POD) (2 arms), sponsored by 904th Hospital of the Joint Logistic Support Force. Primary endpoint: Incidence of postoperative delirium within the first seven days after surgery. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011984.